Helpline 800-723-9166
Donate
Media for Patients

Treatment

July 29, 2000

Treating Plaque Psoriasis from the Inside Out

Next Podcast

Subscribe to our Podcast

Suggest a Podcast Topic

Guest Speaker
Christopher (Chris) McKim
Title
Regional Marketer, Dermatology Division
Bristol Myers Squibb
Guest Speaker
Christine Cornejo, M.D.
Title
Dermatologist and Medical Engagement Lead for Dermatology and Rheumatology
Bristol Myers Squibb
Moderator
Archie Franklin
Title
NPF Volunteer and Patient Advocate

Hear Christopher McKim’s journey from itchy and painful moderate to severe plaque psoriasis to clear skin and the latest clinical trial results from dermatologist, Dr. Christine Cornejo.

Join this discussion with moderator Archie Franklin as Bristol Myers Squibb employees, Christopher McKim, who has moderate to severe plaque psoriasis and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at BMS offer a patient and physician’s perspective on treating plaque psoriasis from the inside out. Listen as Chris presents his journey to clear skin along with Dr. Cornejo addressing clinical trial results for effectiveness and safety information for deucravacitinib, an oral treatment option.

The intent of this episode is to encourage those who have moderate to severe plaque psoriasis to work with their health care provider to find a treatment that effectively treats the systemic nature of the disease.

This episode is sponsored by Bristol Myers Squibb. For more information about SOTYKTU view Full Prescribing Information and Medication Guide.

Key Takeaways:

  • Living with moderate to severe plaque psoriasis can be challenging but there are treatment options that work from the inside out to help relieve symptoms and reduce psoriasis plaques.  
  • Work with a health care provider to find the right treatment to clear moderate to severe plaque psoriasis.
  • Be proactive by taking steps to learn about treatment options including effectiveness, side effects, safety concerns, and what should be discussed with a health care provider before beginning a new treatment for psoriasis. 

Timestamps

  • (0:00) Intro to Psoriasis Uncovered and guest welcome to Bristol Myers Squibb employee and patient Christopher McKim and Dr. Christine Cornejo, Director and US Medical

Engagement Lead for Dermatology and Rheumatology at Bristol Myers Squibb.

  • (2:15)  Where the journey to finding the right treatment option for Chris and his moderate to severe plaque psoriasis began.
  • (3:09)  The decision by Chris and his provider to try an oral systemic medication.
  • (3:28)  The effects and impact of SOTYKTU (deucravacitinib) for Chris and his plaque psoriasis.
  • (4:09)  Dr. Cornejo addresses the efficacy profile of SOTYKTU with results from the POETYK PSO Trials.
  • (5:58)  Common side effects and safety concerns associated with use of SOTYKTU.
  • (6:28)  Health considerations patients and providers should discuss prior to using SOTYKTU.  
  • (6:54)  What to do if side effects occur while taking SOTYKTU.
  • (7:10)  How Chris feels with clearer skin due to taking SOTYKTU.
  • (8:14)  Indication and Important Safety Information for SOTYKTU (deucravacitinib).

Guest Bios

Christopher (Chris) McKim joined BMS in June of 2022. In his current role he is a Regional Marketer for the dermatology division, prior to that he provided support for 9 Therapeutic Area Specialists for the Pacific South District in the GI division.  Prior to joining BMS, Chris worked at a Sanofi, J&J, Leo Pharma and Sun Pharma in various field and home office roles.

Chris resides in beautiful San Diego with his family Susan (wife), Morgan 18, Maddy 16, Mason 14 and two Golden Retrievers and enjoys traveling, cooking and anything associated with the ocean (Deep Sea Fishing, S.C.U.B.A. diving, snorkeling, and boogie boarding).

Dr. Christine Cornejo joined Bristol Myers Squibb in 2024 as Director, Medical Engagement Lead for Dermatology and Rheumatology. Prior to joining BMS, she practiced dermatology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, MA, where she specialized in melanoma and high-risk skin cancer management and served as the Director of Confocal Microscopy. She also served as an Instructor at Harvard Medical School and led the Immunology and Infectious Diseases course for 1st year medical students.

Resources

Current Oral Systemic Treatments

We Are Here to Help.

Dedicated Patient Navigators are here to help you on your journey with psoriatic disease.

Connect to a navigator.
Share
Related Items

Subscribe to our Podcast

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.